MYC and familial pancreatic carcinoma: This led to the identification of the compound UNC10112785 inhibiting CDK9, a protein kinase enhancing MYC protein stability by phosphorylating serine 62 in MBI (Figure 3), whereby substantial MYC destabilization was observed in pancreatic cancer cells (106).